180 related articles for article (PubMed ID: 28881355)
21. Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer.
Li S; Wu Z; Chen Y; Kang Z; Wang H; He P; Zhang X; Hu T; Zhang Q; Cai Y; Xu X; Guan M
Tumour Biol; 2016 Apr; 37(4):5365-74. PubMed ID: 26561474
[TBL] [Abstract][Full Text] [Related]
22. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
[TBL] [Abstract][Full Text] [Related]
23. The SHED-IT weight loss maintenance trial protocol: A randomised controlled trial of a weight loss maintenance program for overweight and obese men.
Young MD; Collins CE; Callister R; Plotnikoff RC; Doran CM; Morgan PJ
Contemp Clin Trials; 2014 Jan; 37(1):84-97. PubMed ID: 24246820
[TBL] [Abstract][Full Text] [Related]
24. Weight loss increases cardiovagal baroreflex function in obese young and older men.
Alvarez GE; Davy BM; Ballard TP; Beske SD; Davy KP
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E665-9. PubMed ID: 15941781
[TBL] [Abstract][Full Text] [Related]
25. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors.
Toriola AT; Liu J; Ganz PA; Colditz GA; Yang L; Izadi S; Naughton MJ; Schwartz AL; Wolin KY
Breast Cancer Res Treat; 2015 Aug; 152(3):637-43. PubMed ID: 26175059
[TBL] [Abstract][Full Text] [Related]
26. Effect of radical prostatectomy on levels of cancer related epitopes in circulating macrophages of patients with clinically localized prostate cancer.
Todenhöfer T; Hennenlotter J; Keller G; Neumann T; Stenzl A; Bedke J
Prostate; 2017 Sep; 77(12):1251-1258. PubMed ID: 28726251
[TBL] [Abstract][Full Text] [Related]
27. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
Kryvenko ON; Epstein JI; Meier FA; Gupta NS; Menon M; Diaz M
Am J Clin Pathol; 2015 Aug; 144(2):271-7. PubMed ID: 26185312
[TBL] [Abstract][Full Text] [Related]
28. Interplay of atherogenic factors, protein intake and betatrophin levels in obese-metabolic syndrome patients treated with hypocaloric diets.
Crujeiras AB; Zulet MA; Abete I; Amil M; Carreira MC; Martínez JA; Casanueva FF
Int J Obes (Lond); 2016 Mar; 40(3):403-10. PubMed ID: 26443337
[TBL] [Abstract][Full Text] [Related]
29. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
30. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
31. Detection of circulating tumor cells in men with localized prostate cancer.
Seiden MV; Kantoff PW; Krithivas K; Propert K; Bryant M; Haltom E; Gaynes L; Kaplan I; Bubley G; DeWolf W
J Clin Oncol; 1994 Dec; 12(12):2634-9. PubMed ID: 7527455
[TBL] [Abstract][Full Text] [Related]
32. Impact of Weight Management on Obesity-Driven Biomarkers of Prostate Cancer Progression.
Bechtel MD; Michel C; Srinivasan P; Chalise P; Parker WP; Mirza M; Thrasher B; Gibbs HD; DiGiovanni J; Hamilton-Reeves J
J Urol; 2024 Apr; 211(4):552-562. PubMed ID: 38299570
[TBL] [Abstract][Full Text] [Related]
33. A time-efficient reduction of fat mass in 4 days with exercise and caloric restriction.
Calbet JA; Ponce-González JG; Pérez-Suárez I; de la Calle Herrero J; Holmberg HC
Scand J Med Sci Sports; 2015 Apr; 25(2):223-33. PubMed ID: 24602091
[TBL] [Abstract][Full Text] [Related]
34. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.
van Dam EW; Roelfsema F; Veldhuis JD; Hogendoorn S; Westenberg J; Helmerhorst FM; Frölich M; Krans HM; Meinders AE; Pijl H
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E615-20. PubMed ID: 14678951
[TBL] [Abstract][Full Text] [Related]
35. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
36. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen.
Demark-Wahnefried W; Robertson CN; Walther PJ; Polascik TJ; Paulson DF; Vollmer RT
Urology; 2004 May; 63(5):900-4. PubMed ID: 15134976
[TBL] [Abstract][Full Text] [Related]
37. SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.
Yu EY; Li H; Higano CS; Agarwal N; Pal SK; Alva A; Heath EI; Lam ET; Gupta S; Lilly MB; Inoue Y; Chi KN; Vogelzang NJ; Quinn DI; Cheng HH; Plymate SR; Hussain M; Tangen CM; Thompson IM
J Clin Oncol; 2015 May; 33(14):1601-8. PubMed ID: 25847934
[TBL] [Abstract][Full Text] [Related]
38. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
[TBL] [Abstract][Full Text] [Related]
39. Corpulence is the crucial factor: association of testosterone and/or obesity with prostate cancer stage.
Jentzmik F; Schnoeller TJ; Cronauer MV; Steinestel J; Steffens S; Zengerling F; Al Ghazal A; Schrader MG; Steinestel K; Schrader AJ
Int J Urol; 2014 Oct; 21(10):980-6. PubMed ID: 24865433
[TBL] [Abstract][Full Text] [Related]
40. Head to Head Comparison of the Chun Nomogram, Percentage Free PSA and Primary Circulating Prostate Cells to Predict the Presence of Prostate Cancer at Repeat Biopsy.
Murray NP; Reyes E; Orellana N; Fuentealba C; Jacob O
Asian Pac J Cancer Prev; 2016; 17(6):2941-6. PubMed ID: 27356715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
